[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"vt-ablation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:vt-ablation":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100650429","phase-4-treatment-based-on-high-precision-cardiac-mapping-100650429",false,"NCT07746336","Treatment Based on High Precision Cardiac Mapping","Treatment Based on High Precision Cardiac Mapping: Advancing Personalized Outcomes Through Optimized Localization","APOLO-VT","Inclusion criteria\n\n* Age ≥18 years.\n* Diagnosis of structural heart disease (ischemic or non-ischemic cardiomyopathy).\n* Documented sustained monomorphic VT (clinical or inducible), or recurrent ICD therapies for VT.\n* Scheduled for catheter ablation of VT according to current international guidelines.\n* Ability to provide written informed consent.\n* Ability to remain upright or seated to allow a video for 3D torso reconstruction for ECGi acquisition.\n\nExclusion criteria\n\n* Age \\\u003C18 years.\n* Pregnant or breastfeeding women.\n* Inability to provide informed consent due to physical or mental condition.\n* Contraindication to computed tomography or cardiac magnetic resonance (magnetic resonance imaging-incompatible devices, claustrophobia).\n* Contraindication to contrast agents (gadolinium allergy or severe renal dysfunction with estimated glomerular filtration rate \\\u003C30 mL\u002Fmin\u002F1.73 m²).\n* Inability to remain upright for torso 3D reconstruction required for ECGi.\n* Life expectancy \\\u003C1 year due to non-cardiac comorbidity.","ALL","18 Years","99 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"PHASE4","APOLO-VT aims to evaluate the feasibility, safety, and clinical impact of an integrated multimodal mapping workflow combining non-invasive structural and functional substrate characterization using Volumetric Electrocardiographic Imaging (ECGi) with invasive Electroanatomical Mapping (EAM) to support Ventricular tachycardia (VT) ablation targeting and verification.",[28,29,30,31],"VT Ablation","Arrhythmic Burden","Implantable Cardioverter-Defibrillator (ICD) Therapies","Slow-conduction Substrate","NOT_YET_RECRUITING","2026-07-31",{"date":35,"type":36},"2026-08-05","ACTUAL",{"date":38,"type":22},"2026-07-15",{"date":40,"type":22},"2028-07-01",{"name":42,"class":43},"Hospital Clinic of Barcelona","OTHER"]